XML 32 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Basis of Presentation (Tables)
9 Months Ended
Sep. 24, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Reportable Segments
The revised reportable segments are as follows:
Research Models and Services
Discovery and Safety Assessment
Manufacturing Support
Research Models
Discovery Services
Microbial Solutions
Research Model Services
Safety Assessment
Avian
 
 
Biologics
 
 
Contract Manufacturing
The following table presents revenue and other financial information by reportable segment:
 
Three Months Ended
 
Nine Months Ended
 
September 24, 2016
 
September 26, 2015
 
September 24, 2016
 
September 26, 2015
 
(in thousands)
RMS
 
 
 
 
 
 
 
Revenue
$
120,928

 
$
117,894

 
$
369,325

 
$
356,570

Operating income
31,224

 
31,427

 
103,055

 
93,581

Depreciation and amortization
5,245

 
5,279

 
15,613

 
16,590

Capital expenditures
2,532

 
3,022

 
5,966

 
12,111

DSA
 
 
 
 
 
 
 
Revenue
$
215,817

 
$
158,272

 
$
594,859

 
$
451,659

Operating income
31,303

 
33,191

 
94,514

 
84,856

Depreciation and amortization
20,671

 
11,509

 
51,228

 
35,060

Capital expenditures
4,509

 
4,277

 
13,860

 
13,756

Manufacturing
 
 
 
 
 
 
 
Revenue
$
88,975

 
$
73,299

 
$
250,459

 
$
201,223

Operating income
26,711

 
18,491

 
73,447

 
55,872

Depreciation and amortization
6,181

 
5,179

 
18,682

 
12,156

Capital expenditures
1,862

 
2,139

 
8,247

 
5,475